Century Therapeutics to present CNTY-813 type 1 diabetes preclinical data at EASD 2026PUBT·Jul 9 at 07:01 AMIPSC-2.76%
New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026Unusual Whales·Jun 8 at 03:06 PMIPSC-2.76%
Graham, Appian And Other Big Stocks Moving Lower In Monday's Pre-Market Sessionbenzinga_article·Jun 8 at 07:04 AMICCM-4.64%IPSC-2.76%
Century Therapeutics shares are trading higher after Mizuho initiated coverage on the stock with an Outperform rating and announced an $8 price target.benzinga_article·May 27 at 01:06 PMIPSC-2.76%FBT-0.57%
Cor appoints Brent Pfeiffenberger to board as independent directorTradingView·May 14 at 07:23 AMIPSC-2.76%BMY+0.94%
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga_article·Apr 2 at 12:05 PMBBH-0.23%SBIO-0.88%
Century Therapeutics, Inc. (NASDAQ:IPSC) Given Average Recommendation of "Moderate Buy" by BrokeragesMarket Beat·Mar 27 at 09:54 AMIBBQ-0.55%BBH-0.23%
Century Therapeutics (NASDAQ:IPSC) SVP Sells $17,959.65 in StockMarket Beat·Mar 16 at 04:03 PMBBH-0.23%IBB-0.44%
